Highlights |
|
New data may change the way patients receive anticoagulation therapy, said Peter Zimetbaum, MD. Find out more |
|
Prevention of heart failure readmissions begins with effective in-hospital treatment and efficient care transitions, said Akshay S. Desai, MD. Find out how |
|
An American Heart Association Scientific Statement about the feasibility and preliminary efficacy of using mobile health technologies to reduce CVD risk behaviors was the cornerstone of the presentation of Lora E. Burke, PhD. Read more here |
|
Nancy Brown, CEO of American Heart Association, highlighted key findings of the AHA's CEO Roundtable conducted to learn more about the state of workplace health and employee perceptions in the United States. Read more here |
|
DISCLAIMER:
This information has been independently developed and provided by the editors of Medical Economics.
The Medical Economics brand and this e-newsletter are in no way affiliated with the conference event or parent organization. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
